Controlled release combination of carbidopa/levodopa

Details Controlled release combination of carbidopa/levodopa Controlled release combination of carbidopa/levodopa

1989-02-24

1990-02-13

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

A61K 920, A61K 922, A61K 926

Patent

active

049007556

ABSTRACT:
A matrix or monolithic drug delivery system for the controlled release of carbidopa and levodopa consists of the two drugs uniformly dispersed in a polymer vehicle at a concentration that is greater than the solubility of either drug in the polymer. Treatment of parkinsonism with the controlled release formulation provides several advantages over treatment with the standard carbidopa/levidopa combinations presently employed.

REFERENCES:
patent: 3995058 (1976-11-01), Hammond et al.
patent: 4021555 (1977-05-01), Seyfried et al.
patent: 4190672 (1980-02-01), Fahn
patent: 4329356 (1982-05-01), Holland
patent: 4389415 (1983-06-01), Scriabine
patent: 4413012 (1983-11-01), Palfreyman et al.
patent: 4421767 (1983-12-01), Palfreyman et al.
patent: 4424235 (1984-01-01), Sheth et al.
patent: 4440740 (1984-04-01), Fix et al.
patent: 4446138 (1984-05-01), Pack
patent: 4469693 (1984-09-01), Bagli et al.
patent: 4469694 (1984-09-01), Bagli et al.
patent: 4469695 (1984-09-01), Bagli et al.
patent: 4497826 (1985-02-01), Narabayashi et al.
patent: 4529603 (1985-07-01), Mori et al.

Affiliated with

Also associated with

Rating

Controlled release combination of carbidopa/levodopa does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release combination of carbidopa/levodopa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release combination of carbidopa/levodopa will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1168483